Upcoming event

Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study

  • Kavalieris L,
  • O'Sullivan P,
  • Frampton C,
  • Guilford P,
  • Darling D,
  • Jacobson E,
  • Suttie J,
  • Raman JD,
  • Shariat SF,
  • Lotan Y

Publication: J Urol. , June 2017

Commented by Piotr Chlosta

A novel noninvasive multigene urine biomarker test for the surveillance of bladder cancer recurrence, The Cxbladder Monitor, offers high sensitivity and high negative predictive value for ruling out urothelial carcinoma. Results suggest potential for deferring or avoiding cystoscopy in bladder cancer patients.